Relay Therapeutics, Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Relay Therapeutics filed its Q3 2026 10-Q on November 4, 2026, covering the period ending September 30, 2026. The filing document itself contains no substantive business disclosures, financial data, transaction details, counterparties, or operational changes in the excerpt provided — only SEC filing metadata and document structure information.
Why this rating
No material facts, financials, or events are disclosed in the text fragment provided. Standard periodic SEC filing only.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.